Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of abnormal cell shape | embryonic stage phenotype of hoip1
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of myotube | embryonic stage phenotype of hoip1
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of muscle cell of lateral longitudinal muscle 1 | embryonic stage phenotype of hoip1
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of muscle cell of lateral transverse muscle 1 | embryonic stage phenotype of hoip1
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of muscle cell of lateral transverse muscle 2 | embryonic stage phenotype of hoip1
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP is a suppressor | partially of muscle cell of lateral transverse muscle 3 | embryonic stage phenotype of hoip1
Expression of 2 copies of Tm2cDNA.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4kirre-rP298 is able to significantly rescue the lateral longitudinal and lateral transverse muscle myotube elongation defects of hoip1 mutant embryos.
Scer\GAL4kirre-rP298-G4/Tm2cDNA.UAS.EGFP partially rescues Df(3R)BSC741/Tm2Δ8-261
Expression of Tm2cDNA.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4kirre-rP298 leads to partial rescue of the myotube elongation defects of Tm2Δ8-261/Df(3R)BSC741 mutant embryos, but does not lead to any significant difference in the size of the dorsal oblique muscle 2 as compared to controls.